Head-to-Head Trial Supports Early CGRP Inhibitor Treatment in Poorly Controlled Migraine

Therapy for SPMS Demonstrates Protection from Physical Disability Progression and Cognitive Impairment

STR1VE-EU: Gene Replacement Therapy in Symptomatic Spinal Muscular Atrophy Is Associated with Substantial Benefit

Delays in Progression of Secondary-Progressive Multiple Sclerosis Persist at 5 years